Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
X Bioscience PCLBKK:XBIO Forward Dividend Yield % is 0.00% as of Aug. 25, 2026. The stock has 6 warning signs investors should review. Among 188 Restaurants companies, X Bioscience PCL ranks worse than 531914.36% on this metric.
As of today (2026-08-25), the Forward Annual Dividend Yield of X Bioscience PCL is 0.00%.
As of today (2026-08-25), the Trailing Annual Dividend Yield of X Bioscience PCL is 0.00%.
BKK:XBIO's Forward Dividend Yield % is not ranked *
in the Restaurants industry.
Industry Median: 1.895 * Ranked among companies with meaningful Forward Dividend Yield % only.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of X Bioscience PCL was 15.70% per year. The lowest was -37.70% per year. And the median was -37.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
X Bioscience PCL (BKK:XBIO) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
X Bioscience PCL Forward Dividend Yield % Related Terms
BKK:XBIO vs SYY, USFD, PFGC: Forward Dividend Yield % Comparison
For the Restaurants subindustry, X Bioscience PCL's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
X Bioscience PCL Forward Dividend Yield % vs Restaurants Industry
For the Restaurants industry and Consumer Cyclical sector, X Bioscience PCL's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where X Bioscience PCL's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
X Bioscience PCL (BKK:XBIO) has a Forward Dividend Yield % of 0.00% as of Aug. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on X Bioscience PCL and its competitors. According to the industry distribution chart, X Bioscience PCL ranks #999999 out of 188 companies in the Restaurants industry.
Is X Bioscience PCL's Forward Dividend Yield % too high?
X Bioscience PCL's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, X Bioscience PCL ranks #999999 out of 188 companies in the Restaurants industry, which is in the bottom quartile relative to peers.
How does X Bioscience PCL's Forward Dividend Yield % compare to SYY and USFD?
According to the Restaurants industry distribution chart, X Bioscience PCL ranks #999999 out of 188 companies for Forward Dividend Yield %. This places X Bioscience PCL in the lower half of its industry. The industry median Forward Dividend Yield % is 1.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Restaurants company?
The median Forward Dividend Yield % among Restaurants companies is 1.90, based on 188 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on X Bioscience PCL and its competitors. For the Restaurants industry, the median Forward Dividend Yield % is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. X Bioscience PCL's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, X Bioscience PCL (BKK:XBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ฿0.10, compared to a current price of ฿0.07 — trading 30% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For X Bioscience PCL (BKK:XBIO), the current Forward Dividend Yield % is 0.00% as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
X Bioscience PCL, along with its subsidiaries, is mainly engaged in selling food and beverages by operating restaurants and bakery shops under the Le Boeuf, Kagonoya, Bake Cheese Tart, Croquant Chou ZakuZaku, and RAPL trademarks. Additionally, the Group is involved in the production and distribution of biological products. It operates in two business segments: the food and beverage sales segment, which generates maximum revenue, and the production and distribution of biological products segment. Geographically, the Group operates only in Thailand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:XBIO has been successfully added to your 
